Long-Term Epidemiological Trends and Regional Disparities in Male Infertility in Central Asia (1991-2023)

Male infertility prevalence rose in 4 of 5 Central Asian countries over 32 years; incidence climbed in all five

Journal: International Journal of Environmental Research and Public Health | Published: 2026-04-06 | Type: Journal Article | PMID: 42074405 Authors: Mukhamediyar et al. (Kazakh National Medical University, Almaty; Istanbul University; Nazarbayev University, Astana) Funding/COI: Not listed

Summary

Using modeled estimates from the Global Burden of Disease 2023 database, this study tracked male infertility burden across Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan from 1990 to 2023. Age-standardized prevalence rose in four countries while Tajikistan bucked the trend with a decline; incidence increased across the board with peak burden concentrated in the 35–39 age bracket. Fixed-effects panel regressions found that alcohol use, drug use, and STIs (excluding HIV) had country-specific — not uniform — associations with the infertility burden, meaning there is no clean regional story to tell.

Claims

• Age-standardized prevalence of male infertility increased in 4 of 5 Central Asian countries from 1990–2023; Tajikistan showed a decline
• Incidence rose in all five countries over the study period
• Peak incidence concentrated at ages 35–39 in most countries; Tajikistan's peak shifted toward a younger cohort
• Alcohol use, drug use, and STIs (excluding HIV) showed heterogeneous, country-specific associations with male infertility burden in fixed-effects panel regression models

Study Quality

This is a secondary analysis of GBD 2023 data — a global modeling effort, not primary data collection. GBD estimates for Central Asian countries are heavily imputed from sparse surveillance data, so the precision implied by age-standardized rates flatters the underlying data quality. The 33-year window is genuinely useful for trend analysis, and fixed-effects panel regression is the right tool for longitudinal cross-country comparisons with time-invariant confounders. The methodology is defensible for what it is: epidemiological modeling with all the caveats that entails.

The regression findings are vague as reported. "Heterogeneous country-specific associations" tells you almost nothing without effect sizes, confidence intervals, or even directional consistency. If alcohol use is positively associated with male infertility burden in Kazakhstan but negatively in Uzbekistan, that's a finding that demands explanation — or at minimum a table. The abstract offers neither.

Red Flags

• GBD estimates for Central Asia are heavily modeled from weak surveillance infrastructure; the confidence intervals around these figures are likely wide and underreported
• No funding or COI disclosed — a transparency problem for any peer-reviewed paper, especially one with policy implications
• Abstract reports no effect sizes from the regression models; "heterogeneous associations" is not a finding, it's a hedge
• Fixed-effects regression on GBD-modeled outcomes does not establish causality — the input data already embeds assumptions about risk factor relationships
• Five countries over 33 years gives a panel of ~165 observations, which is thin for regression models examining multiple behavioral risk factors simultaneously
• Tajikistan's anomalous decline in prevalence alongside a rising incidence is unexplained and potentially contradictory — this deserves scrutiny, not a passing mention

Strengths

• Addresses a genuinely data-sparse region that is underrepresented in global male infertility literature
• 33-year time horizon is long enough to detect real secular trends
• Age-standardized rates enable valid cross-country comparison
• Inclusion of modifiable behavioral risk factors (alcohol, drugs, STIs) goes beyond purely descriptive epidemiology
• Multi-country comparison within a culturally and geographically coherent region is analytically appropriate

Verdict

A useful flag-planting paper for a neglected region, but it is largely a repackaging of GBD model outputs dressed up as original analysis. The core epidemiological finding — rising male infertility burden in most of Central Asia — is credible as a directional signal, not as precise measurement. The regression analysis adds little without reported effect sizes, and the missing funding/COI disclosure is a basic transparency failure. Read this for the regional context; treat the specific numbers with proportional skepticism given the data infrastructure they rest on.